The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Etiology of Insulin Resistance
Open accessAbstract
Type 2 diabetes mellitus is a major cause of morbidity and mortality worldwide, and the prevalence is set to increase dramatically over the coming decades. Understanding the metabolic pathways that lead to type 2 diabetes is therefore an important healthcare objective. Novel investigational techniques based on magnetic resonance spectroscopy (MRS) have allowed real-time insight into the molecular defects in patients with type 2 diabetes, revealing that insulin resistance is a product of decreased insulin-stimulated skeletal muscle glycogen synthesis, which can mostly be attributed to decreased insulin-stimulated glucose transport (Glut 4) activity. This defect appears to be a result of intracellular lipid-induced inhibition of insulin-stimulated insulin-receptor substrate (IRS)-1 tyrosine phosphorylation resulting in reduced IRS-1-associated phosphatidyl inositol 3 kinase activity. The hypothesis that insulin resistance is a result of accumulation of intracellular lipid metabolites (e.g., fatty acyl CoAs, diacylglycerol) in skeletal muscle and hepatocytes is supported by observations in patients and mouse models of lipodystrophy. Furthermore, the increase in hepatic insulin sensitivity observed in patients with type 2 diabetes following weight loss is also accompanied by a significant reduction in intrahepatic fat without any changes in circulating adipocytokines (interleukin-6, resistin, leptin). Finally, recent MRS studies in healthy, lean, elderly subjects and lean insulin-resistant offspring of parents with type 2 diabetes have demonstrated that reduced mitochondrial activity may also lead to increased intramyocellular lipid content and insulin resistance in skeletal muscle in these individuals. In summary, in vivo MRS has proved to be an important tool for elucidating the causal chain of events that causes insulin resistance. Understanding the cellular mechanism(s) of insulin resistance in turn offers the prospect of better targeted and more effective therapeutic interventions for treatment and prevention of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an increased intramyocellar fat content and fatty acid metabolites have been shown to play a pivotal role in the development of insulin resistance in skeletal muscle [11–15].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [13]
In the citing paper
“Dysregulation of fatty acid metabolism plays a pivotal role in the pathogenesis of insulin resistance in skeletal muscle.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,379
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationBraissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Self-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Self-citationMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Self-citation
Flagged first, then by citations
2 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Williamson, 2004, Primary prevention of type 2 diabetes mellitus by lifestyle intervention, Ann Intern Med, 40, 951
- Szczepaniak, 1999, Measurement of intracellular triglyceride stores by 1H spectroscopy, Am J Physiol, 276, E977
- Londos, 1996, Perilipin, Int J Obes Relat Metab Disord, 20, S97
Cited by
Sorted by citations
Items 201–300 of 825
Jiang, X., Goldberg, I. J., & Park, T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_2 · Cited by 75
Hassan, R. H., de Sousa, A. C. P., Mahfouz, R., Hainault, I., Błachnio-Zabielska, A. U., Bourron, O., Koskas, F., Górski, J., Ferré, P., Foufelle, F., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686949 · Cited by 82
Oxidative stress, type 2 diabetes and vitamin D: past, present and future
Nikooyeh, B., & Neyestani, T. R. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2718 · Cited by 76
“As a result of cellular IR, pancreatic β-cells increase insulin secretion leading to hyperinsulinemia [15].”
BackgroundThe Causal Role of Ectopic Fat Deposition in the Pathogenesis of Metabolic Syndrome
Janssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413238 · Cited by 75
Kim, B., Backus, C., Oh, S., & Feldman, E. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121669 · Cited by 74
“IR is the major feature of the cluster of related physiologic dysfunctions known as the metabolic syndrome (glucose intolerance, obesity, dyslipidemia, and hypertension) [64, 65].”
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
Zemel, M. B., & Bruckbauer (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s40840 · Cited by 74
“Although the pathogenesis of insulin resistance in type 2 diabetes mellitus is still not fully understood, there is evidence that accumulation of intracellular lipid metabolites in skeletal muscle and hepatocytes, as observed in obesity or lipodystrophy, leads to impairment in insulin signaling pathways.(33) Moreover,…”
BackgroundInsulin resistance metabolic stress and atherosclerosis
Wang, H. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s308 · Cited by 75
“All of which are impaired in the IR condition (4).”
BackgroundHuang, G., Ge, G., Wang, D., Gopalakrishnan, B., Butz, D. H., Colman, R. J., Nagy, A., & Greenspan, D. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45096 · Cited by 71
Rangwala, S. M., Li, X., Lindsley, L., Wang, X., Shaughnessy, S., Daniels, T. G., Szustakowski, J. D., Nirmala, N., Wu, Z., & Stevenson, S. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.126 · Cited by 72
Han, T., Yu, C., Tian, S., Wang, L., Liang, X., Duan, W., Na, L., & Sun, C. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0469-3 · Cited by 72
Mitochondrial fitness and insulin sensitivity in humans
Szendroedi, J., & Roden, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1153-2 · Cited by 71
“Increased lipid availability will give rise to intracellular lipid metabolites such as long-chain fatty acyl-CoA (LCFA-CoA) which stimulate inflammatory pathways that interfere with insulin signal transduction, ultimately leading to insulin resistance [5].”
BackgroundHeilbronn, L. K., Gregersen, S., Shirkhedkar, D., Hu, D., & Campbell, L. V. (2007) · Diabetes · doi:10.2337/db06-1687 · Cited by 70
“Diabetes 56:2046–2053, 2007 Relatives of individuals with type 2 diabetes are an ideal human model to test for mechanisms in the early development of insulin resistance because approximately two-thirds eventually develop diabetes, and they can be tested before the development of other confounding factors, including hy…”
BackgroundHall, A. M., Soufi, N., Chambers, K. T., Chen, Z., Schweitzer, G. G., McCommis, K. S., Erion, D. M., Graham, M. J., Su, X., & Finck, B. N. (2014) · Diabetes · doi:10.2337/db13-1502 · Cited by 68
“and insulin sensitivity is unclear, there is evidence that several lipid intermediates in the TAG synthesis pathway may activate signaling pathways that lead to impaired insulin signaling (34).”
BackgroundMitrovic, B., Obradovic, M. M., Gluvic, Z. M., Radunovic, M. L., Rizzo, M., Banach, M., & Isenović, E. R. (2022) · Archives of Medical Science · doi:10.5114/aoms/150639 · Cited by 84
“Hyperinsulinaemia is a transitory state, and if the stimulus for insulin secretion persists, pancreatic β cells cannot secrete the amount of insulin sufficient for overcoming hyperglycaemia, leading to IGT or T2DM [9, 19].”
BackgroundElrayess, M. A., Almuraikhy, S., Kafienah, W., Al‐Menhali, A. S., Al‐Khelaifi, F., Bashah, M., Žarković, K., Žarković, N., Waeg, G., Alsayrafi, M., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.015 · Cited by 68
“This contributes to the expansion of visceral fat in IR obese subjects with ectopic fat deposition in the liver, skeletal muscle and other depots such as epicardial fat [8], causing further augmentation of IR in these tissues [9].”
BackgroundUssher, J. R., & Lopaschuk, G. D. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0003-9 · Cited by 68
“While the inhibition of fatty acid oxidation in the heart improves function in the setting of ischemic heart disease, others have postulated that the inhibition of fatty acid oxidation in peripheral tissues, such as the muscle and liver, will exacerbate insulin resistance and type 2 diabetes [7, 42, 66].”
BackgroundJocken, J. W. E., Smit, E., Goossens, G. H., Essers, Y. P. G., van Baak, M. A., Mensink, M., Saris, W. H. M., & Blaak, E. E. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0386-y · Cited by 68
Hsieh, Y., Joo, S. K., Koo, B. K., Lin, H., Lee, D. H., Chang, M. S., Park, J. H., So, Y. H., & Kim, W. K. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.01.020 · Cited by 71
Guo, X., Wang, X. L., Chen, Y., Yuan, Y., Chen, Y. M., Ding, Y., Fang, J., Bian, L. J., & Li, D. S. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.09.012 · Cited by 67
Induced pluripotent stem cells as a model for diabetes investigation
Stępniewski, J., Kachamakova‐Trojanowska, N., Ogrocki, D., Szopa, M., Matłok, M., Beilharz, M., Dyduch, G., Malecki, M. T., Józkowicz, A., & Dulak, J. (2015) · Scientific Reports · doi:10.1038/srep08597 · Cited by 67
Rivas, D. A., Lessard, S. J., Saito, M., Friedhuber, A. M., Koch, L. G., Britton, S. L., Yaspelkis, B. B., & Hawley, J. A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00659.2010 · Cited by 68
“Insulin resistance in skeletal muscle is associated with impairments in the activation, phosphorylation, and expression of major components of the insulin signaling cascade (13, 19, 40).”
BackgroundAnimal models of insulin resistance and heart failure
Velez, M., Kohli, S., & Sabbah, H. N. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9387-6 · Cited by 66
Assessment and Screening of the Risk Factors in Metabolic Syndrome
Kaur, J. (2014) · Medical Sciences · doi:10.3390/medsci2030140 · Cited by 66
“When the secretary capacity of the pancreas is overwhelmed by battling an insulin resistance state, diabetes develops [11].”
BackgroundFactors that may impede the weight loss response to exercise‐based interventions
Boutcher, S. H., & Dunn, S. L. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00621.x · Cited by 73
“A chronic increase in insulin or a disruption to the insulinsignalling pathways could lead to IR resulting in elevated leptin, SNS activation (52) and deposition of hepatic fat (53).”
BackgroundEffects of body weight and alcohol consumption on insulin sensitivity
Paulson, Q. X., Hong, J., Holcomb, V. B., & Núñez, N. P. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-14 · Cited by 65
“One theory is that in obesity, the excess adipose tissue produces high levels of adipokines which promote insulin resistance, on the other hand, the expression of factors that promote insulin sensitivity, such as adiponectin are decreased [11,12].”
BackgroundLi, Y., Tang, Y., Shi, S., Gao, S., Wang, Y., Xiao, D., Chen, T., He, Q. P., Zhang, J., & Lin, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11468 · Cited by 65
Raturi, A., Miersch, S., Hudson, J. W., & Mutus, B. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.003 · Cited by 65
“Loss of insulin sensitivity and resultant hyperglycemia is a hallmark of T2D and several explanations to account for desensitization have been offered including lipid-induced changes in both insulin receptor expression [37] and defective insulin receptor substrate phosphorylation [38].”
BackgroundCinnamon increases liver glycogen in an animal model of insulin resistance
Couturier, K., Qin, B., Batandier, C., Awada, M., Hininger‐Favier, I., Canini, F., Leverve, X. M., Roussel, A., & Anderson, R. A. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.016 · Cited by 70
“[19] Petersen KF, Shulman GI.”
BackgroundDiet, obesity and diabetes: a current update
Walker, C. G., Zariwala, M. G., Holness, M. J., & Sugden, M. C. (2006) · Clinical Science · doi:10.1042/cs20060150 · Cited by 62
Fructose-Containing Sugars and Cardiovascular Disease
Rippe, J. M., & Angelopoulos, T. J. (2015) · Advances in Nutrition · doi:10.3945/an.114.008177 · Cited by 66
Subramanian, S. P., & Prasath, G. S. (2014) · Biomedicine & Preventive Nutrition · doi:10.1016/j.bionut.2014.07.001 · Cited by 64
Burgess, T. A. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.100 · Cited by 65
“Obesity results in a signaling cascade that causes elevated levels of free fatty acids in the bloodstream and excessive lipid deposition in peripheral tissue.(5) This increases skeletal muscle and liver insulin resistance and leads to greater total-body insulin resistance.”
Kaibori, M., Ishizaki, M., Iida, H., Matsui, K., Sakaguchi, T., Inoue, K., Mizuta, T., Ide, Y., Iwasaka, J., Kimura, Y., et al. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2838-8 · Cited by 64
“substrate 1/phosphatidylinositol 3-kinase pathway and growth factor-regulated protein kinase B pathway of insulin signaling.(27) Others have suggested that increased accumulation of lipid intermediates, such as diacylglycerol, long-chain fatty acyl-CoA species, ceramides, and oxidized lipid mediators, resulting from i…”
BackgroundOshaghi, E. A., Goodarzi, M. T., Higgins, V., & Adeli, K. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1343274 · Cited by 62
“Numerous experiments have demonstrated a strong relationship between elevated cytokine levels and IR [127].”
BackgroundThe role of genetics and epigenetics in the pathogenesis of gestational diabetes mellitus
Rosik, J., Szostak, B., Machaj, F., & Pawlik, A. (2019) · Annals of Human Genetics · doi:10.1111/ahg.12356 · Cited by 67
“In both T2DM and GDM, the activity of insulin-stimulated GLUT4 in skeletal muscles is reduced (Fernández-Morera et al., 2010; Petersen & Shulman, 2006).”
BackgroundHatziagelaki, E., Adamaki, M., Tsilioni, I., Dimitriadis, G., & Theoharides, T. C. (2018) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250845 · Cited by 62
“10 hyperglycaemia and the development of Type II diabetes mellitus (T2DM) (Petersen and Shulman, 2006).”
Transgenerational effects of fetal and neonatal exposure to nicotine
Holloway, A. C., Cuu, D. Q., Morrison, K. M., Gerstein, H. C., & Tarnopolsky, M. A. (2007) · Endocrine · doi:10.1007/s12020-007-0043-6 · Cited by 61
Kawaguchi, T., Shiba, N. N., Maeda, T., Matsugaki, T., Takano, Y., Itou, M., Sakata, M., Taniguchi, E., Nagata, K., & Sata, M. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0378-x · Cited by 61
“Down-regulation of the glucose transporter (GLUT) is a cause of insulin resistance and NAFLD [50].”
BackgroundFlavonoids Alleviating Insulin Resistance through Inhibition of Inflammatory Signaling
Ren, N., Kim, E.-H., Li, B., Pan, H., Tong, T., Yang, C. S., & Tu, Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05348 · Cited by 63
Changes in Cells Associated with Insulin Resistance
Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 78
“Low expression of these genes decreases the number of mitochondria in muscle, resulting in intramyocellular fat accumulation in patients with insulin resistance [219,220].”
BackgroundCree‐Green, M., Paddon‐Jones, D., Newcomer, B. R., Rønsen, O., Aarsland, A. A., Wolfe, R. R., & Ferrando, A. A. (2009) · Metabolism · doi:10.1016/j.metabol.2009.09.014 · Cited by 61
“insulin receptor substrate–1 by serine phosphorylation [17,42].”
Lee, B., Hsu, W.-H., Liao, T.-H., & Pan, T. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.07.005 · Cited by 61
Personalized Medicine for Diabetes
Klonoff, D. C. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200301 · Cited by 60
Jung, H. A., Ali, M. Y., Bhakta, H. K., Min, B.-S., & Choi, J. S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0852-3 · Cited by 58
“Insulin resistance is a major pathophysiological factor in the development of T2DM and is defined as a diminished ability of cells, such as myocytes, adipocytes, and hepatocytes, to respond to the action of insulin (Petersen and Shulman 2006).”
BackgroundWadley, G. D., Siebel, A. L., Gj, C., McConell, G. K., Wlodek, M. E., & Owens, J. A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00037.2008 · Cited by 58
“accumulation and insulin resistance in skeletal muscle (11, 17, 18, 23, 26 ), we hypothesized that”
BackgroundInfluentialThe Possible Role of Epigenetics in Gestational Diabetes: Cause, Consequence, or Both
Fernández-Morera, J. L., Rodríguez‐Rodero, S., Torre, E. L. M., & Fraga, M. F. (2010) · Obstetrics and Gynecology International · doi:10.1155/2010/605163 · Cited by 65
“Epigenetic modifications include DNA methylation, histone modification, and those of the microRNA machinery.”
Hartogh, D. J. D., Vlavcheski, F., Giacca, A., & Tsiani, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144900 · Cited by 60
“Insulin resistance and T2DM are strongly associated with elevated plasma FFAs and obesity [37,44,45].”
BackgroundBiomarkers of dysfunctional visceral fat
Gugliucci, A. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.03.001 · Cited by 59
Cellular Mechanisms Underlying the Protective Effects of Preoperative Feeding
Awad, S., Constantin‐Teodosiu, D., Constantin, D., Rowlands, B. J., Fearon, K. C. H., Macdonald, I. A., & Lobo, D. N. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181e8fbe6 · Cited by 57
“Insulin-resistant conditions, such as type 2 diabetes and obesity, have also provided evidence that the development of insulin resistance is associated with skeletal muscle mitochondrial dysfunction.(4,16) Furthermore, studies on semi-starved animals and malnourished patients provided circumstantial evidence that redu…”
BackgroundER Stress Is Implicated in Mitochondrial Dysfunction-Induced Apoptosis of Pancreatic Beta Cells
Lee, J. W., Kim, W., Yeo, J., & Jung, M. H. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0161-5 · Cited by 59
Hussain, G., Rizvi, S. A. A., Singhal, S., Zubair, M., & Ahmad, J. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.02.005 · Cited by 56
“There are multiple metabolic pathways which are dysregulated in T2DM [3,4] and this dysregulation occurs after diagnosis of diabetes or may begin years or even decades before diagnosis of disease [5,6].”
BackgroundBossaert, P., Leroy, J. L. M. R., Campeneere, S. D., Vliegher, S. D., & OPSOMER, G. (2009) · Journal of Dairy Science · doi:10.3168/jds.2009-2218 · Cited by 56
Durg, S., Veerapur, V. P., Neelima, S., & Dhadde, S. B. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.001 · Cited by 59
Physical activity: An effective way to control weight in children?
Maffeis, C., & Castellani, M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.08.006 · Cited by 59
Hoy, A. J., Bruce, C. R., Cederberg, A., Turner, N. A., James, D. E., Cooney, G. J., & Kraegen, E. W. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00133.2007 · Cited by 56
“Insulin resistance has been suggested to be a consequence of defects in the insulin signaling cascade (45).”
BackgroundInteraction between maternal obesity and post-natal over-nutrition on skeletal muscle metabolism
Simar, D., Chen, H., Lambert, K., Mercier, J. G., & Morris, M. J. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.11.007 · Cited by 55
“As the main site of insulin-stimulated glucose disposal, through the translocation of GLUT4 to the plasmamembrane [27], skeletal muscle is critical for glucose homeostasis [30], and reduced GLUT4 levels are associated with insulin resistance and diabetes [21].”
BackgroundDistinct cellular pools of perilipin 5 point to roles in lipid trafficking
Bartholomew, S. R., Bell, E. H., Summerfield, T. L. S., Newman, L. C., Miller, E. L., Patterson, B., Niday, Z., Ackerman, W. E., & Tansey, J. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.017 · Cited by 53
“causal, ectopic neutral lipid storage in liver and muscle is emerging as key factors in the etiology of these diseases [2].”
A New Insight into the Roles of MiRNAs in Metabolic Syndrome
Huang, Y., Yan, Y., Xv, W., Ge, Q., Li, C., Zou, H., & Li, Y. (2018) · BioMed Research International · doi:10.1155/2018/7372636 · Cited by 56
“Because obesity causes fat to accumulate not only in adipocytes, but also in muscle and hepatocytes, leading to IR in these organs [24], in recent years, miRNAs have appeared as novel biomarkers for diagnosis of quite a few diseases.”
BackgroundGrp1 Plays a Key Role in Linking Insulin Signaling to Glut4 Recycling
Li, J., Malaby, A. W., Famulok, M., Sabe, H., Lambright, D. G., & Hsu, V. W. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.03.004 · Cited by 53
“The glucose transporter type 4 (glut4) is expressed selectively in fat and muscle tissues, where it plays a direct role in glucose homeostasis and also has indirect roles in other metabolic events, such as fatty acid biogenesis (Herman and Kahn, 2006; Huang and Czech, 2007; Petersen and Shulman, 2006).”
Birkenfeld, A. L., Boschmann, M., Moro, C., Adams, F., Heusser, K., Tank, J., Diedrich, A., Schroeder, C., Franke, G., Berlan, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1084 · Cited by 53
“(22) Finally, increased NEFA concentrations may have led to a secondary increase in gluconeogenesis and a reduced cellular uptake of glucose.(27) Changes in circulating glucose concentration were associated with changes in glucose utilization at the tissue level.”
BackgroundThe MAGIC investigators, Fontaine‐Bisson, B., Renström, F., Rolandsson, O., Payne, F., Hallmans, G., Barroso, I., & Franks, P. W. (2010) · Diabetologia · doi:10.1007/s00125-010-1792-y · Cited by 51
“For dyslipidaemia, the mechanisms of association with type 2 diabetes primarily involve insulin resistance caused by the infiltration of insulin-sensitive tissues by triacylglycerol and other lipid metabolites [20, 21].”
BackgroundHu, Y., Hou, Z., Liu, D., & Yang, X. (2016) · Food & Function · doi:10.1039/c5fo01467k · Cited by 53
Cree‐Green, M., Newcomer, B. R., Herndon, D. N., Qian, T., Sun, D., Morio, B., Zwetsloot, J. J., Dohm, G. L., Fram, R. Y., Mlcak, R. P., et al. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-9 · Cited by 52
“Liver fat (LFAT) and muscle triglycerides (IMCL) were measured using magnetic resonance spectroscopy as described previously [16], except that the settings of the scans were altered to decrease the amount of time in the machine for the patients.”
BackgroundInfluentialStöhr, R., & Federici, M. (2013) · Biochemical Journal · doi:10.1042/bj20130121 · Cited by 51
The adipokine/ceramide axis: Key aspects of insulin sensitization
Xia, J. Y., Morley, T. S., & Scherer, P. E. (2013) · Biochimie · doi:10.1016/j.biochi.2013.08.013 · Cited by 52
“Although this study correlated intramyocellular triglyceride to insulin resistance, there have been studies suggesting that other intracellular lipids, mainly diacyglycerol and ceramides play a major role in mediating insulin resistance [3,4].”
BackgroundSatapati, S., He, T., Inagaki, T., Potthoff, M. J., Merritt, M. E., Esser, V., Mangelsdorf, D. J., Kliewer, S. A., Browning, J. D., & Burgess, S. C. (2008) · Diabetes · doi:10.2337/db08-0226 · Cited by 52
“Abnormal mitochondrial metabolism is a key feature of insulin-resistant skeletal muscle (17–20) and has been implicated in human insulin-resistant liver (15,16).”
BackgroundLinks between Childhood Obesity, High-Fat Diet, and Central Precocious Puberty
Calcaterra, V., Magenes, V. C., Hruby, C., Siccardo, F., Mari, A., Cordaro, E., Fabiano, V., & Zuccotti, G. (2023) · Children · doi:10.3390/children10020241 · Cited by 60
Simar, D., Jacques, A., & Caillaud, C. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-012-0336-4 · Cited by 51
Fat in Liver/Muscle Correlates More Strongly With Insulin Sensitivity in Rats Than Abdominal Fat
Lim, S. K., Son, K. R., Song, I. C., Park, H. S., Jin, C. J., Jang, H. C., Park, K. S., Kim, Y., & Lee, H. K. (2008) · Obesity · doi:10.1038/oby.2008.486 · Cited by 53
Biswas, S., Tapryal, N., Mukherjee, R., Kumar, R., & Mukhopadhyay, C. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.003 · Cited by 50
Nishiumi, S., Yoshida, M., Azuma, T., Yoshida, K., & Ashida, H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq052 · Cited by 50
“Insulin resistance causes a decline in the response to insulin accompanied by defective glucose uptake activity in adipocytes (Petersen and Shulman, 2006).”
BackgroundSteinberg, G. R., Watt, M. J., Ernst, M., Birnbaum, M. J., Kemp, B. E., & Jørgensen, S. B. (2009) · Diabetes · doi:10.2337/db08-0659 · Cited by 54
“It is well established that obesity is associated with impaired insulin sensitivity in skeletal muscle, and impaired activation of IRS-1 has been attributed a primary role (28,43).”
BackgroundHIV protease inhibitors and obesity
Anuurad, E., Bremer, A. A., & Berglund, L. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833dde87 · Cited by 50
From a glucocentric to a lipocentric approach towards metabolic syndrome
Mittra, S., Bansal, V. S., & Bhatnagar, P. K. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.01.006 · Cited by 48
Janssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105488 · Cited by 70
“This then causes a reduced IRS-1-associated phosphatidyl inositol 3 kinase activity and thereby decreases insulin-stimulated glucose transport (Glut 4) activity (a hallmark of insulin resistance) [81,82].”
BackgroundInfluentialNew Opportunities: Harnessing Induced Pluripotency for Discovery in Diabetes and Metabolism
Teo, A. K. K., Wagers, A. J., & Kulkarni, R. N. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.010 · Cited by 49
Targeting PGC-1α to control energy homeostasis
Wu, Z., & Boss, O. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1329 · Cited by 50
“A large body of literature implicates dysregulation of fatty acid metabolism [6,7,11] , adipose tissue inflammation [12,13] , increased ER stress [14] ,”
BackgroundWu, W. L., Gan, W., Tong, M., Li, X. L., Dai, J.-Z., Zhang, C. M., & Guo, X. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.11.165 · Cited by 48
“Defects in insulin-stimulated glucose uptake in muscle are suggested to be important early events in the pathogenesis of insulin resistance [9,10].”
BackgroundChanséaume, E., & Morio, B. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10010306 · Cited by 50
“Emerging data support the hypothesis that in the particular case of young healthy insulin resistant offspring of parents with type 2 diabetes, alteration in mitochondrial activity would be partly inherited [18-21].”
BackgroundNehlin, J. O., Just, M., Rustan, A. C., & Gaster, M. (2011) · Biogerontology · doi:10.1007/s10522-011-9336-5 · Cited by 53
“mitochondrial function appears to predispose elderly to insulin resistance and type 2 diabetes (Morino et al. 2006; Petersen et al. 2003; Petersen and Shulman 2006).”
BackgroundIn vivo inhibition of focal adhesion kinase causes insulin resistance
Bisht, B., Srinivasan, K. K., & Dey, C. S. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.157107 · Cited by 46
Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice
Kelley, D. S., Vemuri, M., Adkins, Y. C., Gill, S. H. S., Fedor, D. M., & Mackey, B. E. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508027451 · Cited by 49
“Dietary factors that contribute to the development of IR and NAFLD include high-fat (saturated and trans -fatty acids) and high-sucrose diets (11–13) .”
Xu, F., Zhou, X. M., Shen, F., Pang, R. W. C., & Liu, S. M. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03565.x · Cited by 47
Nylander, V., Ingerslev, L. R., Andersen, E., Fabre, O., Garde, C., Rasmussen, M., Citirikkaya, K., Bæk, J., Christensen, G. L., Aznar, M. C., et al. (2016) · Diabetes · doi:10.2337/db16-0364 · Cited by 47
“be due to a lack of adipose tissue plasticity and consequent lipodystrophy after ionizing radiation (42).”
BackgroundRai, U., Kosuru, R., Prakash, S., Singh, S. P., Birla, H., Tiwari, V. K., & Singh, S. K. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116836 · Cited by 46
Awad, S., Stephenson, M. C., Placidi, E., Marciani, L., Constantin‐Teodosiu, D., Gowland, P. A., Spiller, R. E., Fearon, K. C. H., Morris, P. G., Macdonald, I. A., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.01.009 · Cited by 47
Dynamic Tight Glycemic Control During and After Cardiac Surgery Is Effective, Feasible, and Safe
Lecomte, P., Foubert, L. A., Nobels, F. R. E., Coddens, J., Nollet, G., Casselman, F. P. A., Crombrugge, P. V., Vandenbroucke, G., & Cammu, G. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318172c557 · Cited by 46
“This leads to decreased insulinstimulated skeletal muscle glycogen synthesis, which can mostly be attributed to decreased glucose transport (Glut 4) receptor sensitivity.(27) Our preliminary data showed that anticipation of changes in insulin sensitivity during key portions of surgery may be more effective for achievi…”
BackgroundMelatonin and Glucose Metabolism: Clinical Relevance
Lardone, P. J., Álvarez‐Sánchez, N., Guerrero, J. M., & Carrillo‐Vico, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612819666131119101032 · Cited by 47
“T2D is preceded by a lengthy asymptomatic stage characterized by hyperglycemia and insulin resistance [136, 137].”
Backgroundde Wilde, J., Smit, E., Mohren, R., Boekschoten, M. V., de Groot, P., van den Berg, S. A. A., Bijland, S., Voshol, P. J., van Dijk, K. W., de Wit, N. J. W., et al. (2009) · Lifestyle Genomics · doi:10.1159/000308466 · Cited by 47
“Therefore, it has been proposed that not TAG, but lipid intermediates, such as long-chain fatty acyl CoAs, diacylglycerol and ceramides may act as signaling molecules interrupting insulin signaling and glucose metabolism, which eventually results in insulin resistance [”
BackgroundAn islet in distress: β cell failure in type 2 diabetes
Ogihara, T., & Mirmira, R. G. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00021.x · Cited by 46
Chronological Approach of Diet‐induced Alterations in Muscle Mitochondrial Functions in Rats
Chanséaume, E., Tardy, A.-L., Salles, J., Giraudet, C., Rousset, P., Tissandier, A., Boirie, Y., & Morio, B. (2007) · Obesity · doi:10.1038/oby.2007.511 · Cited by 46
Khan, H. B. H., Vinayagam, K. S., Moorthy, B. T., Shanthi, P., & Sachdanandam, P. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0109-1 · Cited by 44
Buchner, D. A., Yazbek, S. N., Solinas, P., Burrage, L. C., Morgan, M. G., Hoppel, C. L., & Nadeau, J. H. (2010) · Obesity · doi:10.1038/oby.2010.214 · Cited by 47
“Insulin resistance is a key factor in the pathophysiological development of T2D and remains the best indicator of future development of T2D among individuals with a family history of the disease (2).”
BackgroundOchman, A. R., Lipinski, C. A., Handler, J. A., Reaume, A. G., & Saporito, M. S. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192187 · Cited by 45
“Type 2 diabetes (T2D) is a metabolic disease that is driven primarily by insulin receptor insensitivity (Petersen and Shulman, 2006).”
BackgroundRole of Calpain-10 in the Development of Diabetes Mellitus and Its Complications
Pánico, P., Salazar, A. M., Burns, A. L., & Ostrosky‐Wegman, P. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.01.005 · Cited by 45
Molecular Genetics of Experimental Hypertension and the Metabolic Syndrome
Pravenec, M., & Kurtz, T. W. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.086900 · Cited by 48
Boström, P., Andersson, L. K., Vind, B. F., Håversen, L., Rutberg, M., Wickström, Y., Larsson, E. N. V., Jansson, P., Svensson, M. K. E., Brånemark, R., et al. (2010) · Diabetes · doi:10.2337/db09-1503 · Cited by 44
“Diabetes 59: 1870–1878, 2010 Insulin resistance plays a major role in the development of type 2 diabetes and is highly related to the accumulation of triglycerides in skeletal muscle (1,2).”
BackgroundRetractedSamadder, A., Das, S., Das, J., & Khuda‐Bukhsh, A. R. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.03.028 · Cited by 43
Jeong, H.-J., Park, S., Yang, W., & Lee, W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.104 · Cited by 43
“Insulin resistance is defined as a decreased responsiveness of the target tissues to ordinary levels of insulin, and is believed to be a central feature of type 2 diabetes and metabolic syndrome [5,6].”
BackgroundHigh-fat and obesogenic diets: current and future strategies to fight obesity and diabetes
Teodoro, J. S., Varela, A. T. I. F., Rolo, A. P., & Palmeira, C. M. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0406-6 · Cited by 45
Metadata
- Authors
- Petersen, K. F., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 119
- Issue
- 5
- Pages
- S10-S16
- ISSN
- 0002-9343 (ISSN-L)
- PMC
- PMC2995525
- OpenAlex
- W1982488301
- Cited by
- 825
- References
- 56
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 18 · 2023: 26 · 2022: 18 · 2021: 34 · 2020: 31 · 2019: 26 · 2018: 25 · 2017: 27 · 2016: 44 · 2015: 41 · 2014: 55 · 2013: 52 · 2012: 43
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG023686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040936)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, type 2 diabetes, IRS-1 tyrosine phosphorylation, PI3K signaling, intracellular lipid accumulation, fatty acyl-CoA, diacylglycerol, lipodystrophy, hepatic insulin sensitivity, weight loss, intrahepatic fat, mitochondrial dysfunction, intramyocellular lipid, magnetic resonance spectroscopy, adipokines
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin Resistance, Mitochondria, Magnetic Resonance Spectroscopy, Obesity, Phosphoproteins, Weight Loss, Thiazolidinediones, Glucose Transporter Type 4, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review